Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01049061
Show Display Options
Rank Status Study
1 Completed A Study of MORAb-003 in Patients With Solid Tumor
Condition: Patients With a Folate-receptor Alpha Expressing Solid Tumor Who Are Not Responsive or Resistant to Standard Therapy and Have no Other Appropriate Treatment.
Intervention: Drug: MORAb-003

Study has passed its completion date and status has not been verified in more than two years.